Asia Pacific Mammalian Cell Fermentation Technology Market Size & Outlook

The mammalian cell fermentation technology market in Asia Pacific is expected to reach a projected revenue of US$ 19,776.4 million by 2030. A compound annual growth rate of 10.7% is expected of Asia Pacific mammalian cell fermentation technology market from 2024 to 2030.
Revenue, 2023 (US$M)
$9,722.9
Forecast, 2030 (US$M)
$19,776.4
CAGR, 2024 - 2030
10.7%
Report Coverage
Asia Pacific

Asia Pacific mammalian cell fermentation technology market, 2018-2030 (US$M)

Asia

Related Markets

Asia Pacific mammalian cell fermentation technology market highlights

  • The Asia Pacific mammalian cell fermentation technology market generated a revenue of USD 9,722.9 million in 2023.
  • The market is expected to grow at a CAGR of 10.7% from 2024 to 2030.
  • In terms of segment, chinese hamster ovary (cho) cell fermentation was the largest revenue generating type in 2023.
  • Human Embryonic Kidney (HEK) Cell Fermentation is the most lucrative type segment registering the fastest growth during the forecast period.
  • Country-wise, China is expected to register the highest CAGR from 2024 to 2030.

Asia Pacific data book summary

Market revenue in 2023USD 9,722.9 million
Market revenue in 2030USD 19,776.4 million
Growth rate10.7% (CAGR from 2023 to 2030)
Largest segmentChinese hamster ovary (cho) cell fermentation
Fastest growing segmentHuman Embryonic Kidney (HEK) Cell Fermentation
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationChinese Hamster Ovary (CHO) Cell Fermentation, Human Embryonic Kidney (HEK) Cell Fermentation, Baby Hamster Kidney (BHK) Cell Fermentation, Murine Myeloma Cell Fermentation
Key market players worldwideThermo Fisher Scientific Inc, Merck KGaA, Danaher Corp, Lonza Group Ltd, Roche Holding AG ADR, Sartorius AG, AstraZeneca PLC, Bristol-Myers Squibb Co, Amgen Inc, Gilead Sciences Inc, Moderna Inc, Regeneron Pharmaceuticals Inc

Other key industry trends

  • In terms of revenue, Asia Pacific region accounted for 22.8% of the global mammalian cell fermentation technology market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 19,776.4 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Mammalian Cell Fermentation Technology Market Companies

Name Profile # Employees HQ Website

Asia Pacific mammalian cell fermentation technology market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to mammalian cell fermentation technology market will help companies and investors design strategic landscapes.


Chinese hamster ovary (cho) cell fermentation was the largest segment with a revenue share of 65.89% in 2023. Horizon Databook has segmented the Asia Pacific mammalian cell fermentation technology market based on chinese hamster ovary (cho) cell fermentation, human embryonic kidney (hek) cell fermentation, baby hamster kidney (bhk) cell fermentation, murine myeloma cell fermentation covering the revenue growth of each sub-segment from 2018 to 2030.


  • Asia Pacific Mammalian Cell Fermentation Technology Type Outlook (Revenue, USD Million, 2018-2030)
    • Chinese Hamster Ovary (CHO) Cell Fermentation
      • End use
        • Biopharmaceutical Companies
        • CMOs & CDMOS
        • Academic And Research Organizations
    • Human Embryonic Kidney (HEK) Cell Fermentation
      • End use
        • Biopharmaceutical Companies
        • CMOs & CDMOS
        • Academic And Research Organizations
    • Baby Hamster Kidney (BHK) Cell Fermentation
      • End use
        • Biopharmaceutical Companies
        • CMOs & CDMOS
        • Academic And Research Organizations
    • Murine Myeloma Cell Fermentation
      • End use
        • Biopharmaceutical Companies
        • CMOs & CDMOS
        • Academic And Research Organizations
    • Others
      • End Use
        • Biopharmaceutical Companies
        • CMOs & CDMOS
        • Academic And Research Organizations

Reasons to subscribe to Asia Pacific mammalian cell fermentation technology market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Asia Pacific mammalian cell fermentation technology market databook

  • Our clientele includes a mix of mammalian cell fermentation technology market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific mammalian cell fermentation technology market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific mammalian cell fermentation technology market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Asia Pacific mammalian cell fermentation technology market size, by country, 2018-2030 (US$M)

Asia Pacific Mammalian Cell Fermentation Technology Market Outlook Share, 2023 & 2030 (US$M)

Asia Pacific mammalian cell fermentation technology market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more